Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Berberine to Prevent Colorectal Adenomas in CRC Patients
NCT03281096Phase 3Completed
- Sponsor
- Xijing Hospital of Digestive Diseases
- Start
- Aug 2017
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of berberine in Colorectal Adenoma (CRA), sponsored by Xijing Hospital of Digestive Diseases. Started Aug 2017; status: completed.
02
Drugs
berberine
03
Conditions
Colorectal Adenoma (CRA)
Beyond the preview
Go deeper on NCT03281096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03281096.